Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

This study has been terminated.
Sponsor:
Collaborators:
University of Minnesota - Clinical and Translational Science Institute
University of Alabama at Birmingham
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00957931
First received: August 12, 2009
Last updated: December 20, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)